The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126074161 12607416 1 I 20160725 20160729 20160729 EXP BR-PFIZER INC-2016362465 PFIZER 82.00 YR M Y 71.00000 KG 20160729 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126074161 12607416 1 PS EFFEXOR XR VENLAFAXINE HYDROCHLORIDE 1 Oral 75 MG, 1X/DAY 20699 75 MG PROLONGED-RELEASE CAPSULE QD
126074161 12607416 2 SS EFFEXOR XR VENLAFAXINE HYDROCHLORIDE 1 20699 PROLONGED-RELEASE CAPSULE
126074161 12607416 3 C CRESTOR ROSUVASTATIN CALCIUM 1 Oral 10 MG, 1 TABLET PER DAY 0 10 MG TABLET
126074161 12607416 4 C LOSARTAN. LOSARTAN 1 Oral UNK 0
126074161 12607416 5 C ATENOLOL. ATENOLOL 1 Oral UNK 0
126074161 12607416 6 C CLOPIDOGREL BISULFATE. CLOPIDOGREL BISULFATE 1 Oral 1 DF, 1 TABLET PER DAY 0 1 DF TABLET
126074161 12607416 7 C SOMALGIN CARDIO ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE 1 Oral UNK, 1X/DAY 0 QD
126074161 12607416 8 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 1 DF, 1 TABLET PER DAY AT FASTENING 0 1 DF TABLET
126074161 12607416 9 C SYNTHROID LEVOTHYROXINE SODIUM 1 0 TABLET
126074161 12607416 10 C ANGIPRESS ATENOLOL 1 Oral 50 MG, 1 TABLET DAILY AT FASTENING 0 50 MG TABLET
126074161 12607416 11 C LANZOPRAZOL LANSOPRAZOLE 1 Oral 40 MG, 1 TABLET AT FASTENING 0 40 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126074161 12607416 1 Depression
126074161 12607416 2 Stress
126074161 12607416 3 Blood cholesterol
126074161 12607416 4 Blood pressure increased
126074161 12607416 5 Blood pressure increased
126074161 12607416 6 Anticoagulant therapy
126074161 12607416 7 Anticoagulant therapy
126074161 12607416 8 Hormone replacement therapy
126074161 12607416 9 Thyroid disorder
126074161 12607416 10 Cardiac disorder
126074161 12607416 11 Abdominal discomfort

Outcome of event

Event ID CASEID OUTC COD
126074161 12607416 OT
126074161 12607416 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126074161 12607416 Activities of daily living impaired
126074161 12607416 Blindness
126074161 12607416 Decreased appetite
126074161 12607416 Depression
126074161 12607416 Dizziness
126074161 12607416 Drug ineffective
126074161 12607416 Eye disorder
126074161 12607416 Hallucination, visual
126074161 12607416 Malaise

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126074161 12607416 1 201506 0
126074161 12607416 3 201506 0
126074161 12607416 4 201506 0
126074161 12607416 5 201506 0
126074161 12607416 6 201506 0
126074161 12607416 7 201506 0
126074161 12607416 8 201306 0
126074161 12607416 10 2011 0